Innovations in Biobanking: NAYO's Latest Solutions
NAYO is thrilled to announce its participation in MEDICA 2024, taking place from November 11 to 14 in Düsseldorf, Germany. This prominent trade fair is expected to gather over 83,000 medical professionals and is one of the largest events in the medical B2B sector. At this event, NAYO will unveil its latest innovations in laboratory automation, showcasing groundbreaking products that promise to transform biobanking processes.
Highlighting Cutting-Edge Biobanking Technology
A significant highlight of NAYO's offerings will be the A8 series of biobanking solutions. This advanced product combines three essential functions: barcode scanning, fraction identification, and tube capping/decapping. The design emphasizes flexibility, allowing users to customize tube capping/decapping operations with various robotic arms and pipetting channels. This adaptability ensures that diverse laboratory requirements can be met efficiently.
Dual-Robotic Arm System
The innovative dual-robotic-arm linkage enhances the capacity for multi-procedure parallel processing. As a result, efficiency in aliquoting and sorting processes is significantly improved, catering to busy laboratories requiring fast turnaround times. The easy-to-configure software supports various sample volumes, making it suitable for labs with fluctuating throughput needs. This remarkable system can handle an array of common tube types, from blood and urine tubes to centrifuge and cryogenic tubes.
Expanding Capabilities with Optional Accessories
The seamless integration of an automated screw capper/decapper and a 2D barcode scanner dramatically boosts operational efficiency. To further enhance functionality, optional accessories for nucleic acid extraction are available, streamlining workflows in genomic studies and research. This thoughtful design addresses the evolving needs of laboratories invested in the future of life sciences.
NAYO's Vision for Future Collaborations
Chandler Luo, the Chief Executive Officer of NAYO, emphasized the importance of MEDICA as a platform to showcase not just products but the company's vision for collaboration with global partners and medical institutions. "This exhibition provides an excellent opportunity for us to engage in discussions that can lead to meaningful partnerships. By utilizing our flexible-based platform, we aim to enhance resource utilization and establish strong connections with medical professionals across the world,” stated Luo.
About NAYO and Its Commitment to Innovation
Founded in 2016, NAYO has emerged as a key player in the laboratory automation market. Headquartered in Shanghai, China, NAYO specializes in creating flexible-based platforms as well as serving as an original equipment manufacturer (OEM). The company's commitment to innovation is evident in its extensive range of over 240 configurations across five primary product categories: liquid handling platforms, integrated equipment, exclusive application products, and essential consumables.
Looking ahead, NAYO remains dedicated to enhancing laboratory efficiency. Continuous improvements in their products and solutions aim to ensure quality and safety in life sciences and clinical diagnostics. Through a commitment to innovation, NAYO is set to redefine what’s possible in laboratory settings.
Frequently Asked Questions
What is NAYO showcasing at MEDICA 2024?
NAYO will showcase their innovative A8 series biobanking solutions, designed to enhance laboratory automation.
What are the key features of the A8 series?
The A8 series features barcode scanning, fraction identification, and tube capping/decapping, along with customizable robotic arms.
Who is the CEO of NAYO?
The CEO of NAYO is Chandler Luo, who aims to foster global collaborations at MEDICA.
What is the focus of NAYO as a company?
NAYO focuses on laboratory automation and developing flexible-based platforms to improve efficiency in life sciences.
When and where is MEDICA 2024 being held?
MEDICA 2024 will be held from November 11 to 14 in Düsseldorf, Germany.
